CG Oncology (CGON) EPS (Basic) (2023 - 2026)

CG Oncology (CGON) posted EPS (Basic) of -$5.24 for Q1 2026, down 877.25% on a QoQ basis from -$0.54 in Q4 2025, and down 227.94% year-over-year from $4.1 in Q1 2025.

CG Oncology (CGON) EPS (Basic) (2023 - 2026) Analysis & Trends

CG Oncology's EPS (Basic) history runs 4 years deep, the most recent figure standing at -$5.24 for Q1 2026.

  • Quarterly EPS (Basic) fell 227.94% year-over-year to -$5.24 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.26 (down 305.24% YoY) and the FY2025 annual result came in at -$2.08, down 47.84% from the prior year.
  • EPS (Basic) was -$5.24 for Q1 2026 at CG Oncology, down from -$0.54 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.28 in Q2 2024 and bottomed at -$5.24 in Q1 2026.
  • A 4-year average of -$2.32 and a median of -$1.94 in 2025 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2024 — EPS (Basic) jumped 92.78% — and 2025, when it plunged 905.37%.
  • CG Oncology's EPS (Basic) stood at -$5.19 in 2023, then soared by 90.2% to -$0.51 in 2024, then dropped by 5.41% to -$0.54 in 2025, then sank by 877.25% to -$5.24 in 2026.
  • Business Quant data shows CGON's EPS (Basic) at -$5.24 in Q1 2026, -$0.54 in Q4 2025, and -$3.06 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 CG Oncology 5.86 Bn 5.86 Bn -1.88 Mn -5.24

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.24
Dec 31, 2025 -0.54
Sep 30, 2025 -3.06
Jun 30, 2025 -1.94
Mar 31, 2025 -1.60
Dec 31, 2024 -0.51
Sep 30, 2024 -0.30
Jun 30, 2024 -0.28
Mar 31, 2024 -0.36
Dec 31, 2023 -5.19
Sep 30, 2023 -4.00
Jun 30, 2023 -3.93
Mar 31, 2023 -3.22